Clinical Trials Logo

Syndrome clinical trials

View clinical trials related to Syndrome.

Filter by:

NCT ID: NCT03282318 Completed - Clinical trials for Interstitial Cystitis

A Study to Investigate Efficacy, Safety, Pharmacodynamics and Pharmacokinetics of ASP6294 in the Treatment of Female Subjects With Bladder Pain Syndrome/Interstitial Cystitis

SERENITY
Start date: September 28, 2017
Phase: Phase 2
Study type: Interventional

The purpose of this study is to investigate efficacy, safety and tolerability of ASP6294 in female participants with Bladder Pain Syndrome/Interstitial Cystitis (BPS/IC). This study will also investigate the pharmacokinetics (PK) and pharmacodynamics (PD) of ASP6294 in female participants with BPS/IC.

NCT ID: NCT03281473 Recruiting - Clinical trials for Acute Respiratory Distress Syndrome

Comparison of Positive End Expiratory Pressure Titration Methods in ARDS Patients

ELSE
Start date: October 2, 2018
Phase: N/A
Study type: Interventional

This study aims at assessing the short-term physiological effects of 2 positive end expiratory pressure titration strategies in patients with ARDS.

NCT ID: NCT03281317 Active, not recruiting - Clinical trials for Vasoplegic Syndrome of Cardiac Surgery

Vasoplegic Syndrome in Cardiac Surgery

ISYVACC
Start date: December 15, 2017
Phase:
Study type: Observational

Vasoplasmic syndrome in cardiac surgery is one of the major postoperative complications.This syndrome is characterized by persistent low blood pressure despite an optimization of preload and inotropism.

NCT ID: NCT03279432 Completed - Obesity Clinical Trials

Vitamin D-related Genes and Metabolic Disorders

Start date: August 18, 2004
Phase: N/A
Study type: Observational

The link between metabolic disturbances and vitamin D receptor (VDR) and MEGALIN (or LRP2) gene polymorphisms remains unclear, particularly among African-American adults. The associations of single nucleotide polymorphisms (SNPs) for VDR [rs1544410(BsmI:G/A), rs7975232(ApaI:A/C), rs731236(TaqI:G/A)] and MEGALIN [rs3755166:G/A,rs2075252:C/T, rs2228171:C/T] genes with incident and prevalent metabolic disturbances, including obesity, central obesity and metabolic syndrome (MetS) were evaluated. From 1,024 African-Americans participating in the Healthy Aging in Neighborhoods of Diversity across the Life Span (HANDLS, Baltimore, MD, 2004-2013) study, 539 subjects were selected who had complete genetic data as well as covariates selected for metabolic outcomes at two consecutive examinations (visits 1 and 2) with a mean follow-up time of 4.64±0.93y. Haplotype (HAP) analyses generated polymorphism groups that were linked to incident and prevalent metabolic disturbances.

NCT ID: NCT03277963 Completed - Obesity Clinical Trials

Perception of Pain During Obstructive Sleep Apnea Syndrome in Obese Patient

Start date: February 4, 2010
Phase: N/A
Study type: Interventional

Obstructive sleep apnea syndrome (SAOS), very commonly associated with obesity, induces major disturbances in sleep architecture. The hypotheses in this work are twofold: on the one hand, the SAOS could generate pain perception disorders in a population already affected by the mechanical weight constraints, generating potentially painful complications, and on the other hand, the improvement of sleep provided by continuous positive airway pressure (PPC) ventilation could "normalize" the pain perception thresholds. It was shown an early rebound effect after treatment on increasing pain threshold in the healthy subject. We want to check it among obese patients with OSA in early and mid-term.

NCT ID: NCT03277690 Completed - Clinical trials for Endogenous Cushing's Syndrome

A Study to Assess the Safety and Efficacy of Levoketoconazole in the Treatment of Endogenous Cushing's Syndrome.

Start date: September 26, 2017
Phase: Phase 3
Study type: Interventional

This is a double-blind, randomized, placebo-controlled withdrawal and rescue/restoration study in subjects with endogenous Cushing's Syndrome (CS) previously treated with single-arm, open-label levoketoconazole that will assess efficacy, safety, tolerability, and pharmacokinetics of levoketoconazole.

NCT ID: NCT03275935 Completed - COPD Asthma Clinical Trials

Evaluation of Inhalation Technique in Patients With COPD, Asthma or ACOS Using a Dry Powder Device (DPI)

Start date: March 1, 2017
Phase: N/A
Study type: Observational [Patient Registry]

This study analyzes the prevalence of patients using inhalation devices via incorrect technique and access the adherence of patients to correct inhalation technique when taught along with their subjective improvement of symptoms.

NCT ID: NCT03275792 Withdrawn - Clinical trials for Hemolytic-Uremic Syndrome

Shiga Toxin Producing Escherichia Coli (STEC) Volume Expansion

Start date: May 2020
Phase: Phase 1
Study type: Interventional

This study will provide feasibility data regarding the conduct of a clinical trail evaluating the use of early aggressive inpatient intravenous rehydration in children with Shiga Toxin producing E. coli infection.

NCT ID: NCT03275480 Recruiting - Clinical trials for Myelodysplastic Syndromes

Institut Paoli Calmettes Myelodysplastic Syndromes Database

Start date: January 18, 2016
Phase:
Study type: Observational [Patient Registry]

Database of Institut Paoli-Calmettes patients diagnosed with Myelodysplastic Syndromes

NCT ID: NCT03274856 Completed - Clinical trials for Prader-Willi Syndrome

A Study of GLWL-01 in Patients With Prader-Willi Syndrome

Start date: February 20, 2018
Phase: Phase 2
Study type: Interventional

The aim of this study is to evaluate efficacy, safety, and pharmacokinetics of GLWL-01 in the treatment of patients with Prader-Willi Syndrome (PWS).